Trial ID: | L2261 |
Source ID: | NCT01181830
|
Associated Drug: |
Magnesium Pidolate
|
Title: |
Effect of Magnesium Administration in Subjects With Family History of Diabetes or Metabolic Syndrome
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Family History of Metabolic Syndrome|Family History of Diabetes
|
Interventions: |
DRUG: magnesium pidolate|DRUG: placebo
|
Outcome Measures: |
Primary: Blood pressure, Blood pressure measured in the lying and standing position (average of three measurements);, 8 weeks | Secondary: other features of metabolic syndrome, especially plasma lipids and HOMA index, 8 weeks|endothelial function, endothelial function as measured non-invasively by ultrasound using the "Flow Mediated Dilatation" (FMD) technique, 8 weeks|arterial stiffness, systemic and local arterial stiffness measured by digital photoplethysmography and by carotid ultrasound, 8 weeks|Inflammation, Markers of inflammation such as C reactive protein, 8 weeks
|
Sponsor/Collaborators: |
Sponsor: Universita di Verona
|
Gender: |
ALL
|
Age: |
ADULT
|
Phases: |
PHASE4
|
Enrollment: |
14
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
Start Date: |
2010-02
|
Completion Date: |
2012-12
|
Results First Posted: |
|
Last Update Posted: |
2013-10-16
|
Locations: |
Azienda Ospedaliera Universitaria Integrata - Division of Internal Medicine C, Verona, VR, 37134, Italy
|
URL: |
https://clinicaltrials.gov/show/NCT01181830
|